Sometimes being Nice is it’s own reward. Companies that kept on paying employees during the pandemic aren’t facing labor shortages. Those who laid off people are struggling to fill positions. and are losing business to those who kept workers on. Compassion is good for business

Nello Mainolfi, CEO of $KYMR, shares his thoughts on Targeted Protein Degradation: The First Proof-of-Mechanism in a Randomized, Placebo-Controlled Study. lifescivc.com/2021/07/target… Nello Mainolfi Kymera Therapeutics #TPD

Together as one ❤️🏴󠁧󠁢󠁥󠁮󠁧󠁿 #BoyFromBrent

this actually warmed my heart tho. respect to gareth

This story is far from over. The future is ours to write.

The highlight of my running career 10 years ago today at European juniors. I may be washed up but I’m looking forward to watching many old friends competing next week in Tokyo. 🏃🏼‍♂️

This amazing work by Adam Cotton in collaboration with Jim Wells is now published in ACS Laura Kiessling ! See the updated story here: dx.doi.org/10.1021/acsche… Now includes a direct comparison of BioReACT-labeled antibodies to Halo/SNAP/CLIP fusions. Must see!

A (dog) Dad with his lad (Winston) 🐶 @ Foothills, Albuquerque instagram.com/p/CTu07qYpptA/…

Excited to share a #bioRxiv preprint of collaborative work between Jim Wells and Robert Blelloch labs to develop a cell-tethered promiscuous biotinylator for the small-scale surface characterization of exosomes. Teamwork makes the dream work! biorxiv.org/content/10.110…

✨ One of our most read articles in the last 12 months! ✨ Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1 by Cotton, Nguyen, Gramespacher, Ian Seiple & Jim Wells  🔓 #OpenAccess fal.cn/3kHsB

It has been a while since we have shared a former pupil's story. Dr Johnson was delighted to be able to watch Adam's PhD lecture via Zoom over Christmas and it is great to see that he is doing so well. staffordgrammar.co.uk/about-stafford… via Interactive Schools Adam Cotton

Excited to finally have this published. Through measuring global translation rates and de novo lipogenesis in mice, we show that with tunicamycin induced UPR-ER lipids are mobilized from adipose to liver (and liver lipid synthesis is decreased). mdpi.com/1422-0067/23/3…

Biopharma co’s fundraising from VCs: a key point you’ll want to address in your pitch is the history of each of your targets. What is the level of validation (particularly genetic) for each of the clinical settings you’re pursuing? Who has tried to drug this target in the...1/5

Small but mighty! This is a video of a killer T cell of the immune system destroying a monstrous ovarian cancer cell. I recently captured this data on a spinning disc confocal microscope.

Leg 1 - Bangkok ✅ That was tough! Hot 🔥 Humid 😰 and warm rain 🌩️🌧️ but the guys got it done! A quick lie down in the airport ... Literally Ian Stringer ⬇️ before heading off to Honolulu ⛱️🌊 First stop Tokyo 🇯🇵 for a quick change of flights Onwards 👍🏼 Bodie Hodges

The boys ran their hearts out 💙 If you can donate anything at all it would be hugely appreciated 🙌🏽 ⬇️⬇️⬇️ Thank you 💙

Thank the meeting organizers for this award! We are having a great time at PEGS Summit! so many cool talks and so wonderful to hang out with Jim Wells alumni

1/3*Unexpected Treatment for Ras cancers* Not only did we uncover the target of a new molecule via CRISPRi but also found that cancers with KRAS G13D and G12V mutations are more sensitive to it. The molecule is patented, licensed and in Phase 1 trials. doi.org/10.1038/s41587…

✨ East District cross country relay champions…. to World Champions!